Is a complete APVO research report available?

No complete published report is available for Aptevo Therapeutics Inc. (APVO) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Aptevo Therapeutics Inc. (APVO)

NASDAQ: APVO · USD

$4.39

+0.02 (+0.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-26 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first APVO analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	5.5M
Net income (ttm)	-26.4M
EPS (ttm)	-$45.5
Shares out	1.2M
Volume	2,505.952
Beta	1.67
Price target	$25.5	+480.9%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -26.4M
EPS (ttm): -$45.5
Market cap: 5.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All APVO indicators

Market & fundamental data

Available fields

170

Groups with data

Currency

USD

Showing 170 of 170 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001671584
Company name	Aptevo Therapeutics Inc.
Country	United States
Country code	US
Cusip	03835L702
Employees	33
Employees Change	-4%
Employees Change Percent	-10.81
Enterprise value	$-4.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US03835L7029
Last refreshed	2026-07-26
Market cap	$5.5M
Market cap category	Nano-Cap
Price	$4.39
Price currency	USD
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.79
Sic	2834
Symbol	APVO
Website	https://aptevotherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-481.74%
FCF yield	-493.24%
P/B ratio	0.46x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-26.4M
Net Income Growth Years	0%
Profit Per Employee	$-798,576
ROA	-118
Roa5y	-55.55
ROCE	-176.1
ROE	-517.9
Roe5y	-179.9
ROIC	-168.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-92.49%
Cagr3y	-98.07%
Cagr5y	-94.85%
EPS Growth Quarters	1
EPS Growth Years	2
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$19.9M
Cash	$14.5M
Current Assets	$16M
Current Liabilities	$4.8M
Debt	$4.4M
Debt Equity	$0.38
Equity	$11.6M
Liabilities	$8.3M
Long Term Assets	$3.9M
Long Term Liabilities	$3.5M
Net Cash	$10.1M
Net Cash By Market Cap	$185
Net Debt Equity	$-0.87
Tangible Book Value	$11.6M
Tangible Book Value Per Share	$9.65
WACC	7.43

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.36
Net Working Capital	$-2.4M
Quick ratio	3.05
Working Capital	$11.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-92.47%
200-day SMA	11.05
3Y total return	-100%
50-day SMA	4.66
50-day SMA vs 200-day SMA	50under200
5Y total return	-100%
All Time High	52,091,878.6
All Time High Change	-100%
All Time High Date	2018-05-17
All Time Low	3.68
All Time Low Change	19.29%
All Time Low Date	2026-07-09
ATR	0.31
Beta	1.67
Beta1y	1.86
Beta2y	0.05
Ch YTD	-53.45
High	4.42
High52	59.4
High52 Date	2025-07-24
High52ch	-92.61%
Low	4.28
Low52	3.68
Low52 Date	2026-07-09
Low52ch	19.29%
Ma50ch	-5.75%
Price vs 200-day SMA	-60.29%
RSI	45.91
RSI Monthly	29.27
RSI Weekly	23.16
Sharpe ratio	-2.2x
Sortino ratio	-2.91
Tr YTD	-53.45
Tr1m	-5.18%
Tr1w	-7.38%
Tr3m	-10.13%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-6.16
Operating Income	$-26.7M
Price target	$25.5
Price Target Change	$481

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,093,630%
Float Percent	87.76%
Shares Insiders	0.06%
Shares Institutions	4.31%
Shares Out	1,246,105
Shares Qo Q	12.1%
Short Float	7.26%
Short Ratio	2.55
Short Shares	6.37

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-27M
Average Volume	98,174x
Bv Per Share	9.65
Ch1m	-5.18
Ch1w	-7.38
Ch1y	-92.47
Ch3m	-10.13
Ch3y	-100
Ch5y	-100
Ch6m	-51.11
Change	0.46%
Change From Open	2.05
Close	4.37
Days Gap	-1.56
Depreciation Amortization	214,000
Dollar Volume	11,001.1
Earnings Date	2026-08-10
Earnings Time	bmo
EBIT	$-26.7M
EBITDA	$-26.5M
EPS	$-45.46
F Score	1
FCF	$-27M
FCF EV Yield	582.44x
FCF Per Share	$-21.65
Financing CF	39,368,000
Fiscal Year End	December
Founded	2,016
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-13
Last Report Date	2026-03-31
Last Split Date	2025-12-30
Last Split Type	Reverse
Last10k Filing Date	2026-03-26
Ma150	6.28
Ma150ch	-30.1%
Ma20	4.44
Ma20ch	-1.1%
Net CF	12,386,000
Next Earnings Date	2026-08-10
Open	4.3
Optionable	No
Position In Range	78.42
Post Close	4.39
Postmarket Change Percent	0.68
Postmarket Price	$4.42
Ppne	3,918,000
Price Date	2026-07-24
Ptbv Ratio	0.47
Relative Volume	0.03x
Share Based Comp	-27,000
Tr6m	-51.11%
Us State	Washington
Volume	2,506

Aptevo Therapeutics Inc. (APVO)

Coverage state: Market snapshot only — no published research

Generate the first APVO analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · APVO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All APVO indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on APVO

Frequently asked questions